Perhaps this is not surprising, despite reports that PD-1+ peripheral blood T cell subsets harbor tumor-specific T cell populations (44), because the expression of PD-1, LAG-3 and TIM-3 alone has not been identified as a predictive biomarker candidate for successful ICB. This evidence concerns the gene HAVCR2 and neoplasm.